15 years of revenue, profit, cash flow and balance-sheet history through FY2026,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 15.1% per year over the past 5 years.
Financial health
The company holds more cash ($10M) than total debt ($4M).
Total debt has grown faster than revenue (14.0% vs -15.1% per year).
Total debt is 0.2× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2026
$72M
-$50M
-23.9%
-52.4%
-28.0%
-15.4%
$12M
$4M
$10M
2025
—
-$12M
—
—
-129.6%
-58.2%
—
—
$1M
2025
$84M
-$73M
-36.7%
-65.6%
-95.5%
-23.9%
-$9M
$12M
$2M
2024
—
-$11M
—
—
-89.2%
-42.5%
—
—
$4M
2023
—
-$15M
—
—
-120.6%
-52.6%
—
—
$9M
2022
—
-$15M
—
—
-59.3%
-36.9%
—
—
$21M
2021
—
-$10M
—
—
-26.2%
-19.9%
—
$2M
$40M
2020
—
-$16M
—
—
-356.9%
-76.8%
—
$2M
$13M
2019
—
-$12M
—
—
-178.5%
-55.4%
—
$3M
$11M
2018
—
-$27M
—
—
-989.4%
-152.9%
—
$5M
$8M
2017
—
-$29M
—
—
-136.1%
-76.7%
—
$7M
$28M
2016
—
-$23M
—
—
-359.4%
-96.1%
—
$7M
$17M
2015
—
-$20M
—
—
-222.4%
-60.8%
—
—
$20M
2014
—
-$34M
—
—
-148.1%
-100.9%
—
—
$25M
2013
—
-$12M
—
—
32.7%
-180.5%
—
—
$805000
Net income
Net income
Return on equity & assets (ROE / ROA)
ROEROA
Shareholders' equity (book value)
Equity
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Mar '26
—
-$7M
—
—
-329.4%
-35.0%
—
—
$4M
Dec '25
—
-$5M
—
—
-51.8%
-23.2%
—
—
$1M
Sep '25
—
-$1M
—
—
-14.7%
-6.6%
—
—
$3M
Jun '25
—
-$3M
—
—
-24.8%
-11.7%
—
—
$5M
Mar '25
—
-$3M
—
—
-22.8%
-10.6%
—
—
$8M
Dec '24
—
-$3M
—
—
-26.9%
-12.8%
—
—
$4M
Sep '24
—
-$2M
—
—
-13.9%
-7.1%
—
—
$8M
Jun '24
—
-$2M
—
—
-20.0%
-9.0%
—
—
$6M
Mar '24
—
-$3M
—
—
-24.4%
-11.8%
—
—
$9M
Dec '23
—
-$3M
—
—
-25.5%
-11.1%
—
—
$9M
Sep '23
—
-$3M
—
—
-22.1%
-10.8%
—
—
$10M
Jun '23
—
-$4M
—
—
-23.8%
-12.4%
—
—
$13M
Mar '23
—
-$4M
—
—
-20.6%
-11.8%
—
—
$16M
Dec '22
—
-$3M
—
—
-12.5%
-7.8%
—
—
$21M
Sep '22
—
-$4M
—
—
-15.0%
-10.9%
—
$2M
$29M
Jun '22
—
-$3M
—
—
-9.4%
-7.3%
—
$2M
$32M
Mar '22
—
-$5M
—
—
-13.8%
-10.4%
—
$2M
$36M
Dec '21
—
-$3M
—
—
-7.7%
-5.8%
—
$2M
$40M
Sep '21
—
-$2M
—
—
-5.0%
-3.9%
—
$2M
$43M
Jun '21
—
-$1M
—
—
-3.2%
-2.4%
—
$2M
$46M
Valuation over time
How the market has priced CHRN against its own fundamentals since 2026-05 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 45.3× (Jun '26) to 41.0× (Sep '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is CHRN growing its revenue and profit?
Over the past 5 years, ChronoScale Corp's revenue has declined 15.1% per year. These are computed facts, not advice.
How much debt does CHRN have?
As of FY2026, ChronoScale Corp reported $4M of total debt against $10M of cash.
What is CHRN's profit margin?
In FY2026, gross margin was -23.9%, operating margin -52.4%, and net margin -70.3%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.